Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Enorama Pharma

0.52 SEK-4.44 %19/11 15:22
Less than 1K followers

ERMA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-4.44 %
-57.00 %
-36.30 %
+81.69 %
-72.98 %
-80.23 %
-79.00 %
-97.18 %
-91.90 %

Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are sold mainly through retailers who sell the product under their own brand. The largest market is found in the Nordic region, but with a share of sales exported globally. Enorama Pharma was founded in 2006 and the headquarters are located in Malmö.

Read more
Market cap
38.49M SEK
Turnover
25.92K SEK
Revenue
2.74M
EBIT %
-2,293.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
27/11
2026

Interim report Q3'26

4/12
2026

Extraordinary general meeting '26

17/2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-11-17 08:50

Notice of extraordinary general meeting and second meeting for liquidation purposes in Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-11-17 08:50

Kallelse till extra bolagsstämma tillika andra kontrollstämma i Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-11-13 16:00

Enorama Pharma AB (publ) ingår låneavtal med huvudägaren DS Global 2 500 000 USD, föreslår att bolagsstämma ska besluta om att införa årlig ränta om 9 % och återställer det egna kapitalet

Enorama Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-11-13 16:00

Enorama Pharma AB (publ) ingår tilläggsavtal till låneavtal med huvudägaren DS Global

Enorama Pharma
Regulatory press release2026-11-13 14:00

Enorama Pharma AB (publ) senarelägger publiceringen av delårsrapporten för tredje kvartalet 2026

Enorama Pharma
Regulatory press release2026-11-13 14:00

Enorama Pharma AB (publ) postpones publication of its interim report for the third quarter of 2026

Enorama Pharma
Regulatory press release2026-10-30 20:30

Enorama Pharma AB (publ) häver avtalet om överlåtelse av nikotintuggummiverksamheten med Aflofarm

Enorama Pharma
Regulatory press release2026-10-28 12:40

Jonas Brisland avgår som CFO för Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-10-21 15:00

Enorama Pharma ingår dels avtal för tillverkning, dels avtal för distribution av NIC-S inom EU och Storbritannien

Enorama Pharma
Press release2026-09-10 12:00

Enorama Pharma AB (publ) erhåller yttrande från U.S. Food and Drug Administration i pågående process vid U.S. District Court for the District of Columbia

Enorama Pharma
Regulatory press release2026-08-19 08:30

Kvartalsrapport - Enorama Pharma AB (publ)

Enorama Pharma
Press release2026-08-14 16:00

Enorama Pharma AB (publ) erhåller besked från FDA om vidhållet Refuse-to-File-beslut avseende PMTA-ansökningar

Enorama Pharma
Regulatory press release2026-07-15 14:55

Enorama Pharma AB (publ) meddelar Bengt Jönssons avgång och utnämningen av Amy Walker som tillförordnad verkställande direktör

Enorama Pharma
Regulatory press release2026-06-16 16:55

ENORAMA PHARMA: BULLETIN FROM THE ANNUAL GENERAL MEETING OF ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release2026-06-16 16:55

ENORAMA PHARMA: KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I ENORAMA PHARMA AB (PUBL)

Enorama Pharma
Regulatory press release2026-05-20 15:30

Enorama Pharma AB (publ) avyttrar nikotintuggummiverksamheten till Aflofarm Farmacja Polska

Enorama Pharma
Regulatory press release2026-05-20 08:30

Kvartalsrapport - Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-05-13 08:30

Kallelse till årsstämma i Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-05-13 08:30

Notice of annual general meeting of Enorama Pharma AB (publ)

Enorama Pharma
Regulatory press release2026-04-24 10:00

Enorama Pharma AB (publ) offentliggör årsredovisning och revisionsberättelse

Enorama Pharma